Skip to main content

CBLN3 Antibody - BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-82995

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-82995-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Format

BSA Free

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of Human CBLN3. Peptide sequence: VCEPGRAAAGGPGGAALGEAPPGRVAFAAVRSHHHEPAGETGNGTSGAIY The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for CBLN3 Antibody - BSA Free

Western Blot: CBLN3 Antibody [NBP2-82995]

Western Blot: CBLN3 Antibody [NBP2-82995]

Western Blot: CBLN3 Antibody [NBP2-82995] - WB Suggested Anti-CBLN3 Antibody. Titration: 1.0 ug/ml. Positive Control: HepG2 Whole Cell

Applications for CBLN3 Antibody - BSA Free

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Format

BSA Free

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: CBLN3

Alternate Names

cerebellin 3 precursor, cerebellin-3, PRO1486

Gene Symbol

CBLN3

Additional CBLN3 Products

Product Documents for CBLN3 Antibody - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CBLN3 Antibody - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...